Clinical Validation of AI-Powered Complement and Autoimmune Panel Interpretation: Multi-Parameter Analysis for Enhanced Diagnostic Accuracy in Lupus, Rheumatoid Arthritis, and Thyroid Autoimmunity Assessment

Background: Autoimmune disorders affecting the complement system and producing autoantibodies such as antinuclear antibodies (ANA) and anti-thyroid peroxidase (anti-TPO) impact millions of individuals globally, requiring accurate laboratory interpretation for early diagnosis and effective disease management. This study validates an artificial intelligence (AI) system utilizing a 2.78 trillion parameter neural network for automated complement and autoimmune panel interpretation. Methods: We conducted a multi-center retrospective validation study analyzing 423,891 autoimmune panel results including C3 and C4 complement levels, ANA titers with immunofluorescence patterns, anti-TPO antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and haptoglobin assays from 127 countries between January 2024 and December 2025. Results: The AI system demonstrated 98.4% overall diagnostic accuracy (95% CI: 98.1-98.7%) for autoimmune condition detection. For systemic lupus erythematosus (SLE) detection, sensitivity was 97.6% and specificity was 98.1%. For thyroid autoimmunity assessment, sensitivity was 98.2% and specificity was 97.8%. Complement consumption pattern recognition achieved 96.9% accuracy for distinguishing active lupus flares from quiescent disease. Conclusions: AI-powered autoimmune panel interpretation demonstrates clinical-grade accuracy comparable to expert rheumatologists and immunologists while significantly reducing diagnostic turnaround time from 48-72 hours to less than 60 seconds. These findings support implementation of AI-assisted blood test interpretation as a clinical decision support tool for autoimmune disease diagnosis and monitoring. Keywords: artificial intelligence, machine learning, complement system, C3, C4, antinuclear antibodies, ANA, anti-TPO, autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, clinical decision support, neural network diagnostics

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-23
DOI
https://doi.org/10.5281/zenodo.18353988
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Validation of AI-Powered Complement and Autoimmune Panel Interpretation: Multi-Parameter Analysis for Enhanced Diagnostic Accuracy in Lupus, Rheumatoid Arthritis, and Thyroid Autoimmunity Assessment

Sarah Mitchell, Hans Weber, Th Klein
Zenodo (CERN European Organization for Nuclear Research)
Systemic Lupus Erythematosus Research
article

Clinical Validation of AI-Powered Complement and Autoimmune Panel Interpretation: Multi-Parameter Analysis for Enhanced Diagnostic Accuracy in Lupus, Rheumatoid Arthritis, and Thyroid Autoimmunity Assessment

Sarah Mitchell, Hans Weber, Th Klein
article en

Abstract

Background: Autoimmune disorders affecting the complement system and producing autoantibodies such as antinuclear antibodies (ANA) and anti-thyroid peroxidase (anti-TPO) impact millions of individuals globally, requiring accurate laboratory interpretation for early diagnosis and effective disease management. This study validates an artificial intelligence (AI) system utilizing a 2.78 trillion parameter neural network for automated complement and autoimmune panel interpretation. Methods: We conducted a multi-center retrospective validation study analyzing 423,891 autoimmune panel results including C3 and C4 complement levels, ANA titers with immunofluorescence patterns, anti-TPO antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and haptoglobin assays from 127 countries between January 2024 and December 2025. Results: The AI system demonstrated 98.4% overall diagnostic accuracy (95% CI: 98.1-98.7%) for autoimmune condition detection. For systemic lupus erythematosus (SLE) detection, sensitivity was 97.6% and specificity was 98.1%. For thyroid autoimmunity assessment, sensitivity was 98.2% and specificity was 97.8%. Complement consumption pattern recognition achieved 96.9% accuracy for distinguishing active lupus flares from quiescent disease. Conclusions: AI-powered autoimmune panel interpretation demonstrates clinical-grade accuracy comparable to expert rheumatologists and immunologists while significantly reducing diagnostic turnaround time from 48-72 hours to less than 60 seconds. These findings support implementation of AI-assisted blood test interpretation as a clinical decision support tool for autoimmune disease diagnosis and monitoring. Keywords: artificial intelligence, machine learning, complement system, C3, C4, antinuclear antibodies, ANA, anti-TPO, autoimmune diseases, systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, clinical decision support, neural network diagnostics

Zenodo (CERN European Organization for Nuclear Research)
Kaneka (United States) (US)
Openalex Percentile: Top 81%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Validation of AI-Powered Complement and Autoimmune Panel Interpretation: Multi-Parameter Analysis for Enhanced Diagnostic Accuracy in Lupus, Rheumatoid Arthritis, and Thyroid Autoimmunity Assessment — Sarah Mitchell, Hans Weber, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS